Globe Life (GL, Life & Health Insurance) Stock Valuation & Fair Value Fairly valued
Globe Life (GL, Life & Health Insurance) trades at a blended P/E of 11.9 — about 2% below its historical normal valuation — with a forward growth estimate of 7.6% and a PEG of 1.56. Analysts' one-year estimates have been hit 82% of the time.
Valuation flags
- No notable valuation flags.
Verdict history
tickerseer's rating has been fairly valued since 2026-06-03.
Frequently asked questions
Is Globe Life stock overvalued?
At a blended P/E of 11.9 versus its historical normal P/E of 12.1, Globe Life trades about 2% below its typical valuation, with a PEG of 1.56 on 7.6% forward growth — tickerseer currently rates it fairly valued.
What is Globe Life's fair value and PEG?
Globe Life trades at a blended P/E of 11.9 against a historical normal P/E of 12.1, a PEG of 1.56, and a forward growth estimate of 7.6%.
Has tickerseer's rating of Globe Life changed?
tickerseer's rating has been fairly valued since 2026-06-03.
Industry: Life & Health Insurance. Create a free account to unlock the full analysis — the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.